Newbang Biotechnology

Nanjing Newbang Biotechnology (NNB) is a biotechnology company that develops and manufactures novel raw materials for the dietary supplement industry. The company was founded by Qilin Liao, who serves as the chairman and was recognized as one of the '10 Most Influential Business Leaders of 2022' by CIO Business Review.

NNB operates with a focus on scientific research and innovation, supported by a 3,000-square-meter R&D laboratory designated as the Nanjing Engineering Technology Research Center in 2021. The firm's global team consists of over 100 scientists from more than 10 countries who have designed and delivered 100 unique raw materials. Newbang's business model involves providing high-quality ingredients to well-known brands and offering technical support for innovators in the health and nutrition space. The company serves a global market, with business operations spanning multiple countries.

The company's intellectual property portfolio is extensive, with 79 invention patents pending, including 31 PCT applications, and 9 granted invention patents across China, the United States, and Australia. It has also registered 99 trademarks domestically and internationally. Newbang has earned several qualifications, such as 'National High-tech Enterprise' and 'Jiangsu Province Specialized, Refined, and New Little Giant Enterprise'.

Keywords: dietary supplements, raw materials, biotechnology, nutritional ingredients, health and wellness, R&D, ingredient development, nutraceuticals, food supplements, health products, bioscience, custom ingredients, nutrition industry, ingredient manufacturing, health innovation, scientific research, global ingredients, supplement formulation